![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MOSPD1 |
Gene summary for MOSPD1 |
![]() |
Gene information | Species | Human | Gene symbol | MOSPD1 | Gene ID | 56180 |
Gene name | motile sperm domain containing 1 | |
Gene Alias | DJ473B4 | |
Cytomap | Xq26.3 | |
Gene Type | protein-coding | GO ID | GO:0000122 | UniProtAcc | Q9UJG1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
56180 | MOSPD1 | LZE4T | Human | Esophagus | ESCC | 5.94e-08 | 2.35e-01 | 0.0811 |
56180 | MOSPD1 | LZE5T | Human | Esophagus | ESCC | 5.22e-03 | 2.17e-01 | 0.0514 |
56180 | MOSPD1 | LZE7T | Human | Esophagus | ESCC | 6.15e-06 | 3.67e-01 | 0.0667 |
56180 | MOSPD1 | LZE20T | Human | Esophagus | ESCC | 2.71e-03 | 5.58e-02 | 0.0662 |
56180 | MOSPD1 | LZE22T | Human | Esophagus | ESCC | 4.38e-02 | 1.88e-01 | 0.068 |
56180 | MOSPD1 | LZE24T | Human | Esophagus | ESCC | 3.11e-14 | 3.75e-01 | 0.0596 |
56180 | MOSPD1 | LZE6T | Human | Esophagus | ESCC | 5.37e-08 | 5.52e-01 | 0.0845 |
56180 | MOSPD1 | P1T-E | Human | Esophagus | ESCC | 3.16e-02 | 8.19e-02 | 0.0875 |
56180 | MOSPD1 | P2T-E | Human | Esophagus | ESCC | 5.01e-29 | 4.23e-01 | 0.1177 |
56180 | MOSPD1 | P4T-E | Human | Esophagus | ESCC | 8.06e-22 | 4.70e-01 | 0.1323 |
56180 | MOSPD1 | P5T-E | Human | Esophagus | ESCC | 1.70e-04 | 4.01e-02 | 0.1327 |
56180 | MOSPD1 | P8T-E | Human | Esophagus | ESCC | 7.42e-15 | 1.48e-01 | 0.0889 |
56180 | MOSPD1 | P9T-E | Human | Esophagus | ESCC | 1.14e-09 | 2.02e-01 | 0.1131 |
56180 | MOSPD1 | P10T-E | Human | Esophagus | ESCC | 8.00e-39 | 6.70e-01 | 0.116 |
56180 | MOSPD1 | P11T-E | Human | Esophagus | ESCC | 9.37e-10 | 2.17e-01 | 0.1426 |
56180 | MOSPD1 | P12T-E | Human | Esophagus | ESCC | 1.42e-23 | 2.94e-01 | 0.1122 |
56180 | MOSPD1 | P15T-E | Human | Esophagus | ESCC | 5.47e-15 | 2.47e-01 | 0.1149 |
56180 | MOSPD1 | P16T-E | Human | Esophagus | ESCC | 6.00e-14 | 7.74e-02 | 0.1153 |
56180 | MOSPD1 | P17T-E | Human | Esophagus | ESCC | 1.03e-05 | 2.51e-01 | 0.1278 |
56180 | MOSPD1 | P19T-E | Human | Esophagus | ESCC | 3.50e-04 | 5.85e-01 | 0.1662 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MOSPD1 | SNV | Missense_Mutation | novel | c.402N>T | p.Lys134Asn | p.K134N | Q9UJG1 | protein_coding | tolerated(0.43) | benign(0.065) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
MOSPD1 | SNV | Missense_Mutation | novel | c.631N>T | p.Leu211Phe | p.L211F | Q9UJG1 | protein_coding | tolerated(0.14) | benign(0.089) | TCGA-AX-A3G9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
MOSPD1 | SNV | Missense_Mutation | novel | c.238N>T | p.Arg80Cys | p.R80C | Q9UJG1 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MOSPD1 | SNV | Missense_Mutation | novel | c.418N>C | p.Ser140Arg | p.S140R | Q9UJG1 | protein_coding | tolerated(0.18) | benign(0.011) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
MOSPD1 | SNV | Missense_Mutation | novel | c.403G>A | p.Glu135Lys | p.E135K | Q9UJG1 | protein_coding | tolerated(0.59) | benign(0.003) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MOSPD1 | SNV | Missense_Mutation | c.152N>G | p.Lys51Arg | p.K51R | Q9UJG1 | protein_coding | tolerated(0.1) | probably_damaging(0.936) | TCGA-BS-A0TJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
MOSPD1 | SNV | Missense_Mutation | c.395G>T | p.Arg132Ile | p.R132I | Q9UJG1 | protein_coding | tolerated(0.09) | benign(0.147) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
MOSPD1 | SNV | Missense_Mutation | novel | c.215N>G | p.Gln72Arg | p.Q72R | Q9UJG1 | protein_coding | tolerated(0.79) | benign(0.011) | TCGA-E6-A2P9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MOSPD1 | SNV | Missense_Mutation | c.169N>T | p.Pro57Ser | p.P57S | Q9UJG1 | protein_coding | deleterious(0.01) | probably_damaging(0.991) | TCGA-EO-A22X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unspecific | Carboplatin | Complete Response | |
MOSPD1 | SNV | Missense_Mutation | novel | c.372N>C | p.Gln124His | p.Q124H | Q9UJG1 | protein_coding | tolerated(0.1) | possibly_damaging(0.579) | TCGA-EO-A3AV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | CR |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |